Abbott Laboratories (ABT) Tops Q4 EPS by 4c; Raises FY12 Guidance
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $88.21 -0.23%
Revenue Growth %: +9.8%
Financial Fact:
Cost of products sold: 2.29B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +9.8%
Financial Fact:
Cost of products sold: 2.29B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Abbott Laboratories (NYSE: ABT) reported Q4 EPS of $1.03, $0.04 better than the analyst estimate of $0.99. Revenue for the quarter came in at $9.46 billion versus the consensus estimate of $9.35 billion.
Abbott Laboratories sees FY2012 EPS of $5.00-$5.10, versus prior guidance of $4.95-$5.05 and the consensus of $5.01.
For earnings history and earnings-related data on Abbott Laboratories (ABT) click here.
Abbott Laboratories sees FY2012 EPS of $5.00-$5.10, versus prior guidance of $4.95-$5.05 and the consensus of $5.01.
For earnings history and earnings-related data on Abbott Laboratories (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alphabet slides over 6% as AI brain drain and SpaceX slump converge
- Worried the AI trade has gone too far? Evercore likes these 4 stocks
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
